Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Research Journal

The science, examined.

Plain-spoken notes on the compounds we supply — what the literature shows, how to read a COA, and the protocols that protect your data. Cited, never hyped.

All Bioregulators Comparisons Guides Gut Hormonal Immune In the news Metabolic & longevity Methods & QC Nootropics Regulation Sexual health Skin & matrix Sleep Tissue repair
What Is MK-777 (“Acetamoren”)? A Search for a Compound That Has No Dossier Hormonal
Latest

What Is MK-777 (“Acetamoren”)? A Search for a Compound That Has No Dossier

A compound circulating under the names MK-777 and acetamoren is described as a next-generation ghrelin receptor agonist, a successor to MK-677 (ibutamoren). We went looking for the paperwork that would…

Aug 2026 · 7 min read
Every Growth Hormone Secretagogue, Ranked by Evidence Hormonal

Every Growth Hormone Secretagogue, Ranked by Evidence

A ranking of GH secretagogues — tesamorelin, MK-677, GHRP-2, sermorelin, CJC-1295, ipamorelin — by the quantity and quality of human and regulatory evidence, not…

Jul 2026 · 8 min read
What Is IGF-1 DES(1-3)? The Truncated IGF-1 Variant, Compared to LR3 Hormonal

What Is IGF-1 DES(1-3)? The Truncated IGF-1 Variant, Compared to LR3

DES(1-3)IGF-1 is a natural truncated IGF-1 missing three N-terminal residues, giving reduced IGFBP binding, higher in-vitro potency and a short half-life.

Jul 2026 · 7 min read
What Is Follistatin-344? The Myostatin-Binding Protein Variant Hormonal

What Is Follistatin-344? The Myostatin-Binding Protein Variant

Follistatin-344 (FS344) is the follistatin cDNA isoform used in AAV gene-therapy muscle trials. What it binds, how it differs from FS288, and what the…

Jul 2026 · 5 min read
What Is Hexarelin? The GH Secretagogue With a Cardiac Side-Story Hormonal

What Is Hexarelin? The GH Secretagogue With a Cardiac Side-Story

Hexarelin is a synthetic GHRP-family hexapeptide that releases GH via GHS-R1a — and, in rodent hearts, binds CD36. A cited, RUO-only research overview.

Jul 2026 · 5 min read
What Is GHRP-2 (Pralmorelin)? The Growth Hormone-Releasing Peptide, Examined Hormonal

What Is GHRP-2 (Pralmorelin)? The Growth Hormone-Releasing Peptide, Examined

GHRP-2 (pralmorelin, KP-102) is a synthetic ghrelin-mimetic GH secretagogue. What the peptide is, how it works, and its Japan-only diagnostic status, examined.

Jul 2026 · 7 min read
What Is GHRP-6? The Original Growth Hormone-Releasing Hexapeptide Hormonal

What Is GHRP-6? The Original Growth Hormone-Releasing Hexapeptide

GHRP-6 is the prototype growth hormone-releasing hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2). Its chemistry, GHS-R1a and CD36 pharmacology, and the honest evidence.

Jul 2026 · 6 min read
Sermorelin: The Secretagogue With a Real Licence and a Narrow Mandate Hormonal

Sermorelin: The Secretagogue With a Real Licence and a Narrow Mandate

GRF(1-29) is the rare growth-hormone peptide with a genuine regulatory past — approved, marketed as Geref, then withdrawn for commercial reasons. But its documented…

Jun 2026 · 5 min read
Kisspeptin-10: the master switch the body wrote, and pharmacology hasn’t finished Hormonal

Kisspeptin-10: the master switch the body wrote, and pharmacology hasn’t finished

The decapeptide that orders GnRH neurons when to fire is among the best-mapped pieces of human reproductive physiology — and, candidly, still a research…

Jun 2026 · 5 min read
Tesamorelin: The Only GH-Axis Peptide With an FDA Licence — And What That Doesn’t Mean Hormonal

Tesamorelin: The Only GH-Axis Peptide With an FDA Licence — And What That Doesn’t Mean

A stabilised GHRH(1-44) analogue is the one growth-hormone secretagogue in this catalogue with a regulatory approval behind it. That approval is narrow, conditional, and…

Jun 2026 · 5 min read
Enclomiphene: The Evidence Card. Every Study, Every Trial, and Why Regulators Said No Hormonal

Enclomiphene: The Evidence Card. Every Study, Every Trial, and Why Regulators Said No

Enclomiphene evidence card: 107 PubMed articles classified, all 25 registered trials, and why the FDA and EMA turned down Androxal and EnCyzix, from source.

Jun 2026 · 35 min read

New research, in your inbox

Occasional, considered notes on the compounds and the literature. No noise.

Subscribe & earn 500 points